322 results found

Competition law has evolved from a specialized legal domain into a critical enterprise risk that demands board-level attention. How can corporate directors effectively oversee antitrust compliance and protect their companies from regulatory exposure in an era of heightened enforcement?

Verisk's $2.35 billion acquisition of AccuLynx faced unexpected FTC scrutiny, leading to a Delaware Court of Chancery ruling that prevented Verisk from abandoning the deal. Legal experts dissect the antitrust challenges, the FTC's novel "market reset" theory, and critical lessons for drafting merger agreements in an evolving regulatory landscape.

Looking forward to presenting at the AIPLA IP Practice in Japan Mid-Winter Program in Houston, TX next week!

Every trial tells a story — but what happens when the storyteller becomes the judge? Managing Partner Jeny Maier joins Anora Wang as co-host for a wide-ranging conversation with the Honorable Judge Richard Franklin Boulware II about his extraordinary path from public defender to federal judge, and the lessons he's learned about persuasion, fairness, and the fine art of trial craft.

As we navigate the ever-evolving terrain of technology and market dynamics, it's vital to stay ahead with insights that transcend the moment. Partners Denise Plunkett and Bradley Justus...

Axinn partner Daniel Bitton and counsel Carol Liu co-authored the Tijdschrift Mededingingsrecht in de Praktijk article, "Biden's Antitrust Gamble."

Axinn Managing Partner Jeny Maier joins fashion and luxury industry counsel Andowah Newton and co-host Puja Patel on the American Bar Association's Our Curious Amalgam podcast to explore what happens when antitrust law meets high fashion.

On May 10, 2024, the USPTO posted a notice of proposed rulemaking (NPRM) soliciting comments regarding a proposed change concerning terminal disclaimers used to overcome non-statutory double patenting.

Federal enforcers continue to refine the tools they use in merger enforcement—including the use of prior approval provisions, once considered an extraordinary remedy in merger settlements.

Axinn partner Lisl Dunlop hosted AHLA's Speaking of Health Law podcast in an episode entitled, "Antitrust Agency Update: A Conversation with FTC Assistant Director Mark Seidman.

Axinn partner Jeny Maier co-hosted ABA's Our Curious Amalgam podcast in an episode entitled, "Can Competition and Quality Coincide? Analyzing a Systematic Competition...

Managing Partner Jeny Maier and co-host Puja Patel welcome Baker McKenzie attorneys David Baay and Katia Boneva-Desmicht to the ABA Antitrust Section's podcast Our Curious Amalgam...

Managing Partner Jeny Maier appeared on the Capitol Forum's ABA Spring 2025 Interview Series to discuss the antitrust M&A enforcement landscape under the new Trump administration.

Many practitioners wonder what it would be like to be an academic, diving deeply into the leading international legal and policy issues at the forefront of antitrust and competition law.

State attorneys general are taking a more active role in merger control, with Colorado and Washington leading the way on new "mini-HSR" pre-merger notification regimes.

The US antitrust agencies' approach to merger remedies has undergone a significant change under the Biden administration. Remedies are increasingly disfavored.

State attorneys general are playing an increasingly important role in antitrust enforcement.

Expanding the range of ways they can identify and investigate potential competition concerns in healthcare, DOJ, FTC, and HHS recently announced the introduction of HealthyCompetition.gov...